Ramsay Health Care Limited (ASX:RHC)
Australia · Delayed Price · Currency is AUD 40.95
-0.04 (-0.10%)
At close: Mar 18, 2026
Ramsay Health Care Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 18,619 | 17,792 | 16,660 | 14,964 | 13,312 | 12,864 | |
Revenue Growth (YoY) | 8.95% | 6.79% | 11.34% | 12.41% | 3.48% | 5.79% |
Cost of Revenue | 16,409 | 15,676 | 14,646 | 13,320 | 11,924 | 11,274 |
Gross Profit | 2,210 | 2,115 | 2,014 | 1,644 | 1,389 | 1,590 |
Other Operating Expenses | -17.4 | -45.1 | -111.9 | - | - | - |
Operating Expenses | 1,150 | 1,081 | 970.2 | 986.5 | 927.6 | 899.4 |
Operating Income | 1,060 | 1,034 | 1,044 | 657.6 | 460.9 | 690.7 |
Interest Expense | -616.7 | -621.8 | -620 | -514.2 | -389 | -398.1 |
Interest & Investment Income | 13.4 | 17.4 | 7 | 39.9 | 36.2 | 7.1 |
Earnings From Equity Investments | - | - | - | - | 0.2 | 10.9 |
EBT Excluding Unusual Items | 456.2 | 429.9 | 430.6 | 183.3 | 108.3 | 310.6 |
Merger & Restructuring Charges | -0.9 | -0.9 | - | - | - | - |
Impairment of Goodwill | 248.4 | - | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | 67.9 | 24.2 | 24.2 |
Asset Writedown | -272 | -327.2 | -46 | -14.3 | -11.3 | -21.5 |
Other Unusual Items | - | - | - | 290.2 | 402 | 428.3 |
Pretax Income | 431.7 | 101.8 | 384.6 | 527.1 | 523.2 | 741.6 |
Income Tax Expense | 146.4 | 55.5 | 121.3 | 181.5 | 159.3 | 230.1 |
Earnings From Continuing Operations | 285.3 | 46.3 | 263.3 | 345.6 | 363.9 | 511.5 |
Earnings From Discontinued Operations | - | - | 618.1 | 19.9 | 15.3 | - |
Net Income to Company | 285.3 | 46.3 | 881.4 | 365.5 | 379.2 | 511.5 |
Minority Interest in Earnings | 4.3 | -22.3 | 7.3 | -67.4 | -105.2 | -62.5 |
Net Income | 289.6 | 24 | 888.7 | 298.1 | 274 | 449 |
Preferred Dividends & Other Adjustments | 16.6 | 17.2 | 16.7 | 13 | 9 | 9.1 |
Net Income to Common | 273 | 6.8 | 872 | 285.1 | 265 | 439.9 |
Net Income Growth | 1044.66% | -97.30% | 198.12% | 8.80% | -38.98% | 58.10% |
Shares Outstanding (Basic) | 230 | 229 | 229 | 228 | 228 | 228 |
Shares Outstanding (Diluted) | 231 | 230 | 229 | 228 | 228 | 228 |
Shares Change (YoY) | 0.50% | 0.48% | 0.22% | 0.04% | -0.04% | 9.34% |
EPS (Basic) | 1.19 | 0.03 | 3.82 | 1.25 | 1.16 | 1.93 |
EPS (Diluted) | 1.19 | 0.03 | 3.81 | 1.25 | 1.16 | 1.93 |
EPS Growth | 3444.22% | -99.22% | 205.20% | 7.50% | -39.72% | 47.59% |
Free Cash Flow | 712.6 | 704.2 | 539 | 558.7 | 7 | 852.3 |
Free Cash Flow Per Share | 3.09 | 3.06 | 2.35 | 2.45 | 0.03 | 3.73 |
Dividend Per Share | 0.825 | 0.800 | 0.800 | 0.750 | 0.970 | 1.515 |
Dividend Growth | 3.13% | - | 6.67% | -22.68% | -35.97% | 142.40% |
Gross Margin | 11.87% | 11.89% | 12.09% | 10.99% | 10.43% | 12.36% |
Operating Margin | 5.69% | 5.81% | 6.26% | 4.40% | 3.46% | 5.37% |
Profit Margin | 1.47% | 0.04% | 5.23% | 1.91% | 1.99% | 3.42% |
Free Cash Flow Margin | 3.83% | 3.96% | 3.23% | 3.73% | 0.05% | 6.63% |
EBITDA | 1,660 | 1,593 | 1,588 | 1,172 | 950.7 | 1,163 |
EBITDA Margin | 8.91% | 8.95% | 9.53% | 7.83% | 7.14% | 9.04% |
D&A For EBITDA | 600.1 | 558.5 | 544.3 | 514.3 | 489.8 | 472.5 |
EBIT | 1,060 | 1,034 | 1,044 | 657.6 | 460.9 | 690.7 |
EBIT Margin | 5.69% | 5.81% | 6.26% | 4.40% | 3.46% | 5.37% |
Effective Tax Rate | 33.91% | 54.52% | 31.54% | 34.43% | 30.45% | 31.03% |
Revenue as Reported | 18,649 | 17,854 | 16,779 | 15,369 | 13,776 | 13,332 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.